Follow the people · Insider
Gregory Austin Ciongoli
Gregory Austin Ciongoli files insider transactions with the SEC as a director of Regenxbio (RGNX). We hold 2 disclosed purchases and sales filed since 12 August 2025, 2 of them in the last 90 days.
- Files forRGNX
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure27 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 25 August 2026 — 27 August 2026Director · Regenxbio (RGNX)4 Form 4 lines · source: SEC Form 4
- Filed 9 June 2026 — 9 June 2026Director and 10% owner and Other role · Atara Biotherapeutics (ATRA)1 Form 4 line · source: SEC Form 4
- Filed 11 August 2025 — 12 January 2026Director · Zymeworks (ZYME)6 Form 4 lines · source: SEC Form 4
Everything they disclosed
11 entries, newest first — one per disclosure report, one per Form 4 line- was granted 15,432 shares of RegenxbioSEC Form 427 August 2026Common Stock · traded 25 August 2026 · filed 27 August 2026
- ▲ bought on the open market 49,196 shares of RegenxbioSEC Form 427 August 2026Common Stock · traded 26 August 2026 · filed 27 August 2026
- ▲ bought on the open market 53,407 shares of RegenxbioSEC Form 427 August 2026Common Stock · traded 27 August 2026 · filed 27 August 2026
- was granted 69,609 shares of Regenxbio (a derivative holding)SEC Form 427 August 2026Stock Options (Right to buy) · traded 25 August 2026 · filed 27 August 2026
- was granted 12,000 shares of Atara BiotherapeuticsSEC Form 411 June 2026Common Stock · traded 9 June 2026 · filed 11 June 2026
- was granted 11,500 shares of Zymeworks (a derivative holding)SEC Form 412 January 2026Stock Option (Right to Buy) · traded 12 January 2026 · filed 12 January 2026
- was granted 7,700 shares of Zymeworks (a derivative holding)SEC Form 412 January 2026Restricted Stock Unit · traded 12 January 2026 · filed 12 January 2026
- was granted 11,500 shares of Zymeworks (a derivative holding)SEC Form 412 January 2026Stock Option (Right to Buy) · traded 12 January 2026 · filed 12 January 2026
- was granted 7,700 shares of Zymeworks (a derivative holding)SEC Form 412 January 2026Restricted Stock Unit · traded 12 January 2026 · filed 12 January 2026
- was granted 62,000 shares of Zymeworks (a derivative holding)SEC Form 412 August 2025Stock Option (Right to Buy) · traded 11 August 2025 · filed 12 August 2025
- was granted 415,000 shares of ZymeworksSEC Form 412 August 2025Common Stock · traded 12 August 2025 · filed 12 August 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.